I. Matsumoto

A novel antagonist of the prostaglandin E2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models

T. Sumida, K. Ackermann, M. Spyvee, 2010, British journal of pharmacology.